BioMarin Pharmaceutical Inc. is a company in the U.S. stock market and it is a holding in 94 U.S.-traded ETFs. BMRN has around 12.8M shares in the U.S. ETF market. The largest ETF holder of BMRN is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.88M shares. Investors may also find of interest that the ETF with the largest allocation to BMRN stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 4.07%. On average, U.S. ETFs allocate 0.41% of BMRN to their portfolios.
Additionally, BMRN is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BMRN as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 38.22%.